Stem cells in pulmonary hypertension: Current understanding and future challenges

Stem cells in pulmonary hypertension: Current understanding and future challenges

Saved in:

Bibliographic Details
Main Authors:	Xiaoyi Hu, Jinming Liu, Xiao Song, Ping Yuan
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	Animal Models and Experimental Medicine
Subjects:	pulmonary hypertension stem cells
Online Access:	https://doi.org/10.1002/ame2.12482
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Epidemiology, Burden, Risk Factors, Presentations, and Challenges of Evaluating and Managing Patients with Pulmonary Hypertension in Nigeria – A Short Review
by: Oluwafemi Tunde Ojo, et al.
Published: (2024-12-01)

Cardiopulmonary exercise testing in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Alexis Coulis, et al.
Published: (2024-11-01)

Tadalafil Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells-Derived Exosomes in Pulmonary Hypertension by Upregulating miR-29a-3p
by: Liu Y, et al.
Published: (2024-12-01)

Screening and management of pulmonary arterial hypertension in systemic sclerosis
by: Vivek Nagaraja, et al.
Published: (2017-01-01)

Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions
by: Ioan Teodor Dragoi, et al.
Published: (2024-12-01)

Echocardiographic index for pulmonary hypertension discrimination in patients after pulmonary embolism - pilot study
by: M. Peneva, et al.
Published: (2024-12-01)

New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01)

Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland
by: Markku Pentikäinen, et al.
Published: (2024-12-01)

From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach
by: Parham Shahidi, et al.
Published: (2024-11-01)

A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats
by: Yan Xu, et al.
Published: (2025-01-01)

Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta‐analysis of randomized controlled trials
by: Weijun Li, et al.
Published: (2024-10-01)

Revisiting hemodynamic definition: Incidence of chronic thromboembolic pulmonary hypertension following acute intermediate-high and high-risk pulmonary embolism
by: Bárbara Lacerda Teixeira, et al.
Published: (2024-12-01)

A CASE REPORT OF CHRONIC PULMONARY THROMBOEMBOLISM AND ACCOMPANYING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: CHRONIC PULMONARY THROMBOEMBOLISM AND HYPERTENSION
by: Emrah Dogan, et al.
Published: (2022-12-01)

Management of patients with pulmonary arterial hypertension against systemic sclerodermia (part 2).
by: O. O. Khaniukov, et al.
Published: (2019-01-01)

Management of patients with pulmonary arterial hypertension against of systemic sclerodermia (part 1).
by: Ye. D. Yehudina, et al.
Published: (2018-11-01)

Hypoxia-Induced Mitochondrial ROS and Function in Pulmonary Arterial Endothelial Cells
by: Harrison Wang, et al.
Published: (2024-11-01)

Risk Factors of Pulmonary Hypertension in Patients on Hemodialysis; Mitral Regurgitation is a Classic Cause of Secondary Pulmonary Hypertension [Letter]
by: Naser A
Published: (2024-11-01)

Early Echocardiographic Findings of Pulmonary Hypertension-specific Therapy in Children
by: Akif KAVGACI, et al.
Published: (2023-12-01)

Relevance of patient-centered actigraphy measures in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a qualitative interview study
by: Rachael Kendrew, et al.
Published: (2024-12-01)

Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results from a cohort in Brazil
by: Fabio Solano de Freitas Souza, et al.
Published: (2025-01-01)

Pulmonary hypertension during high‐dose GM‐CSF therapy of autoimmune pulmonary alveolar proteinosis
by: Ali Ataya, et al.
Published: (2024-10-01)

Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
by: Meng Li, et al.
Published: (2024-12-01)

Clinicolaboratory characteristics and 1-year survival among group 1 pulmonary hypertension in a university hospital
by: Mostafa K. Ahmed, et al.
Published: (2024-12-01)

Right ventricular stroke work index in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A retrospective observational study
by: Györgyi Csósza, et al.
Published: (2024-10-01)

The possibilities of lung perfusion scintigraphy in the diagnosis of pulmonary embolism and chronic thromboembolic pulmonary hypertension
by: V.Yu. Kundin, et al.
Published: (2017-06-01)

The contemporary echocardiography approach to diagnosis of pulmonary hypertension and non-invasive estimation of pulmonary artery pressure
by: M.Yu. Kolesnyk
Published: (2018-06-01)

Does the Use of Direct Oral Anticoagulants Influence the Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism?
by: Takeshi Ogo
Published: (2024-11-01)

Perioperative anesthetic challenges in pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: A case series
by: Khushboo Mehta, et al.
Published: (2025-01-01)

Rheumatoid arthritis presenting by combined pulmonary fibrosis and emphysema with clubbing and pulmonary hypertension: A rare case report
by: Reza Basiri, et al.
Published: (2024-11-01)

Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective
by: Leslie Marisol Gonzalez-Hermosillo, et al.
Published: (2024-11-01)

Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01)

Safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension
by: Cara Morgan, et al.
Published: (2024-10-01)

Association between the prognosis and comorbidity of active cancer in chronic thromboembolic pulmonary hypertension
by: Hiroyuki Fujii, et al.
Published: (2025-01-01)

Establishment of mouse models for severe pulmonary hypertension through ‘double‐hit’ strategies
by: Lingdan Chen, et al.
Published: (2024-12-01)

Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)
by: Markku Pentikäinen, et al.
Published: (2025-02-01)

Development and validation of a mortality predictive model for ICU patients with primary pulmonary hypertension
by: Chao-Yong Zhang, et al.
Published: (2024-12-01)

Dicrotic notch index in pulmonary hypertension: correlation with hemodynamic, echocardiographic and clinical parameters
by: Mustafa Oguz, et al.
Published: (2024-11-01)

Systolic function of the left ventricle in patients with pulmonary hypertension on the background of chronic obstructive pulmonary disease
by: I. M. Fushtey, et al.
Published: (2020-04-01)

THBS1 mediates hypoxia driven EndMT in pulmonary hypertension
by: Bingming Peng, et al.
Published: (2024-10-01)

Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials
by: Casandra E. Besse, et al.
Published: (2024-10-01)